undamentalytics Newsletter

Teladoc Health vs Waystar Holding

Teladoc Health is the larger business, with $2.53bn of revenue in fiscal 2025 against $1.10bn for Waystar Holding (2.3 times as much). Waystar Holding grew faster (16.5% against -1.5%). Waystar Holding kept more of each dollar of sales as profit: a net margin of 10.2% against -7.9%.

Latest fiscal yearTeladoc HealthTDOC, 2025Waystar HoldingWAY, 2025
Revenue $2.53bn $1.10bn
Revenue growth -1.5% 16.5%
Net income −$200m $112m
Operating margin — 22.7%
Net margin -7.9% 10.2%
Return on equity -13.9% 3.2%
Free cash flow $285m $283m
Cash $781m $61.4m
Total debt $995m $1.48bn
Debt to equity — 38.2%
Dividend per share — —
Dividend yield — —
Share buybacks — $0
Employees 5,600 1,700
Market value $1.62bn $5.34bn
Price vs our value range Below our value range Within our value range
Moat score 36 (Weak) —
Insider trades, 12 months 1 buys, 37 sales 1 buys, 12 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.